Atairos acquisition of LifeLabs Learning
We are advising Atairos on the transaction
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
European Biotech Acquisition $220 million combination with Oculis
We advised European Biotech Acquisition on its de-SPAC transaction
Sun Pharmaceutical acquisition of Concert Pharmaceuticals
We advised Sun Pharmaceutical on the transaction
Priveterra Acquisition initial business combination with AEON Biopharma
We are advising Priveterra on the transaction
TMS ¥2.9 billion global IPO
The shares are listed on the Tokyo Stock Exchange
Metalmark Capital up to $50 million investment in Morgenesis
We advised Metalmark on the transaction
Molded Devices acquisition of GlobalMed and Schauenburg-Truplast
We advised Molded Devices on the acquisition and the related financing arrangements
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
European Biotech Acquisition $200 million combination with Oculis
We are advising European Biotech Acquisition Corp. on its deSPAC transaction
Novo Nordisk $1.1 billion acquisition of Forma Therapeutics
We are advising Novo Nordisk on the transaction